These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1875553)

  • 21. [Use of megazol for the treatment of trypanosomiasis].
    Bouteille B; Chauviere G
    Med Trop (Mars); 1999; 59(4):321-30. PubMed ID: 10816740
    [No Abstract]   [Full Text] [Related]  

  • 22. Zoonotic trypanosomes in South East Asia: Attempts to control Trypanosoma lewisi using veterinary drugs.
    Desquesnes M; Yangtara S; Kunphukhieo P; Chalermwong P; Jittapalapong S; Herder S
    Exp Parasitol; 2016 Jun; 165():35-42. PubMed ID: 26988923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA]: a purine analogue with trypanocidal activity in vitro and in vivo.
    Kaminsky R; Schmid C; Grether Y; Holý A; DeClercq E; Naesens L; Brun R
    Trop Med Int Health; 1996 Apr; 1(2):255-63. PubMed ID: 8665394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistance in Trypanosoma evansi.
    Gill BS
    Trop Anim Health Prod; 1971; 3(4):195-8. PubMed ID: 5164595
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficacy of furazolidone against experimental infections with Trypanosoma evansi in camels and mice in Sudan: comparisons with quinapyramine and suramin.
    Ali BH; Hassan T; Malik KH
    Rev Elev Med Vet Pays Trop; 1986; 39(2):197-201. PubMed ID: 3589066
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility of Brazilian isolates of Trypanosoma evansi to suramin sodium: test in experimentally infected mice.
    Faccio L; Da Silva AS; Gressler LT; Tonin AA; Lazzarotto CR; Miletti LC; Monteiro SG
    Exp Parasitol; 2013 Jul; 134(3):309-12. PubMed ID: 23562880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo action of terpinen-4-ol, γ-terpinene, and α-terpinene against Trypanosoma evansi.
    Baldissera MD; Grando TH; Souza CF; Gressler LT; Stefani LM; da Silva AS; Monteiro SG
    Exp Parasitol; 2016 Mar; 162():43-8. PubMed ID: 26773165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma brucei: an evaluation of salicylhydroxamic acid as a trypanocidal drug.
    Opperdoes FR; Aarsen PN; van der Meer C; Borst P
    Exp Parasitol; 1976 Oct; 40(2):198-205. PubMed ID: 971725
    [No Abstract]   [Full Text] [Related]  

  • 29. [Compounds for treatment of trypanosoma infections].
    Clement B
    Pharm Unserer Zeit; 1989 Jul; 18(4):97-111. PubMed ID: 2672033
    [No Abstract]   [Full Text] [Related]  

  • 30. Heat shock protein 90 as a potential drug target against surra.
    Rochani AK; Mithra C; Singh M; Tatu U
    Parasitology; 2014 Aug; 141(9):1148-55. PubMed ID: 24912527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isometamidium chloride and homidium chloride fail to cure mice infected with Ethiopian Trypanosoma evansi type A and B.
    Mekonnen G; Mohammed EF; Kidane W; Nesibu A; Yohannes H; Van Reet N; Büscher P; Birhanu H
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006790. PubMed ID: 30208034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The possible use of Trypanosoma musculi infection in mice as a screening test for potential Trypanosoma cruzi-active drugs.
    Jennings FW; Gray GD
    Z Parasitenkd; 1982; 67(3):245-8. PubMed ID: 6814086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose finding of 3'deoxyadenosine and deoxycoformycin for the treatment of Trypanosoma evansi infection: An effective and nontoxic dose.
    Dalla Rosa L; Da Silva AS; Oliveira CB; Gressler LT; Arnold CB; Baldissera MD; Sagrillo M; Sangoi M; Moresco R; Mendes RE; Weiss PE; Miletti LC; Monteiro SG
    Microb Pathog; 2015 Aug; 85():21-8. PubMed ID: 26025154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current state of the problem of antibiotic therapy of trypanosomiases].
    Egorov NS; Sukhareva-Nemakova NN; Titova TS
    Izv Akad Nauk SSSR Biol; 1983; (1):5-19. PubMed ID: 6338072
    [No Abstract]   [Full Text] [Related]  

  • 35. Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains.
    Chena MA; Elizondo S; Rodríguez-Páez L; Nogueda B; Baeza I; Wong C
    J Enzyme Inhib Med Chem; 2005 Apr; 20(2):189-97. PubMed ID: 15968824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma evansi infection in dogs: seasonal prevalence and chemotherapy.
    Singh B; Kalra IS; Gupta MP; Nauriyal DC
    Vet Parasitol; 1993 Oct; 50(1-2):137-41. PubMed ID: 8291188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zoonotic trypanosomes in South East Asia: Attempts to control Trypanosoma lewisi using human and animal trypanocidal drugs.
    Desquesnes M; Yangtara S; Kunphukhieo P; Jittapalapong S; Herder S
    Infect Genet Evol; 2016 Oct; 44():514-521. PubMed ID: 27491458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya.
    Otsyula M; Kamar K; Mutugi M; Njogu AR
    Acta Trop; 1992 Feb; 50(3):271-3. PubMed ID: 1348603
    [No Abstract]   [Full Text] [Related]  

  • 39. Nerolidol-loaded nanospheres prevent hepatic oxidative stress of mice infected by Trypanosoma evansi.
    Baldissera MD; Souza CF; Grando TH; Dolci GS; Cossetin LF; Moreira KL; DA Veiga ML; DA Rocha MI; Boligon AA; DE Campos MM; Stefani LM; DA Silva AS; Monteiro SG
    Parasitology; 2017 Feb; 144(2):148-157. PubMed ID: 27748203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotechnological interventions for treatment of trypanosomiasis in humans and animals.
    Prayag K; Surve DH; Paul AT; Kumar S; Jindal AB
    Drug Deliv Transl Res; 2020 Aug; 10(4):945-961. PubMed ID: 32383004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.